Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.
Takahito Yazaki(Georgetown University), R I Glazer, Samuel D. Rabkin(Massachusetts General Hospital), Nickolas M. Dean, Ester Zylber‐Katz, R L Martuza(Georgetown University), Shakeel Ahmad(University of Lahore), Ali Chahlavi
Cited by 104
Related Papers
Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma
|Nature|1988|670
Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
|Cancer Research|2009|358
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
|Neuro-Oncology|2011|239
Modulation of Transcription Factor Sp1 by cAMP-dependent Protein Kinase
|Journal of Biological Chemistry|1997|207